<?xml version="1.0" encoding="UTF-8"?>
<p>Artemether is often used in combination with lumefantrine. One of the commercial versions of this combination, Coartem
 <sup>®</sup>, was used in a prospective observational study in Mali in children (6 months–10 years) coinfected with HCMV and malaria. Viral load in the urine decreased but only in high virus shedders [
 <xref rid="B64-microorganisms-08-00085" ref-type="bibr">64</xref>]. The artemether-lumefantrine combination was also used in patients infected with EBOV, showing reduced efficacy in reducing the risk of death compared to that of AS-AQ, as already described in the “Artesunate” paragraph [
 <xref rid="B58-microorganisms-08-00085" ref-type="bibr">58</xref>].
</p>
